Diagnostics For All
- Company typePrivate
- Founded2007
- HeadquartersSalem, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Diagnostics For All does
Diagnostics For All (DFA) is a non-profit enterprise based in Salem, United States, founded in 2007 to develop low-cost diagnostic tools for healthcare and agricultural applications in the developing world. The organization focuses on populations and healthcare facilities lacking access to conventional laboratory infrastructure, with a stated mission of saving lives and improving health outcomes in resource-limited settings.
The company's core technology is paper microfluidics — diagnostic devices built on paper substrates that enable point-of-care testing without the need for laboratory equipment. This approach is positioned as a cost-efficient alternative to traditional lab diagnostics, targeting use cases such as early disease detection in remote or under-resourced environments. DFA offers a portfolio of paper-based diagnostic products in this category.
As a non-profit, Diagnostics For All does not operate a traditional commercial revenue model; pricing is not publicly disclosed and the organization is structured for social impact rather than shareholder returns. Distribution and awareness are described as likely channeled through partnerships with international health organizations, NGOs, and government health ministries rather than conventional commercial distribution. The company is co-founded by Hayat al-Sindi (PhD in biotechnology, University of Cambridge, 2001) and chaired by Carmichael Roberts.
Diagnostics For All firmographics
Firmographics- Name
- Diagnostics For All
- Legal name
- Diagnostics for All
- Website
- https://dfa.org
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Diagnostics For All industry classification
Industry- Product category
- Point-of-Care Diagnostics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
Keywords
Where Diagnostics For All is headquartered
LocationHeadquarters
- HQ city
- Salem
- HQ country
- United States
- HQ region
- North America
Markets served
Diagnostics For All business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
Diagnostics For All product offering
Product offeringCore offering
Diagnostics For All develops and produces low-cost paper-based diagnostic tools using proprietary paper microfluidics technology. The devices are designed for point-of-care testing in resource-limited healthcare settings in the developing world, where conventional laboratory diagnostics are unavailable or unaffordable, enabling early disease detection and improved health outcomes in underserved populations.
Product overview
Diagnostics For All (DFA) is a non-profit enterprise that creates low-cost paper-based diagnostic tools. The organization fuses biotechnology and device development to address health challenges in developing regions. The company offers a portfolio of paper-based diagnostic products designed for point-of-care use in low-resource environments.
Differentiator
Problem solved
Functional benefit
Products and services
- Low-Cost Paper-Based Diagnostic Tools Non-profit diagnostic tools utilizing paper microfluidics technology, designed for low-cost, point-of-care testing in resource-limited healthcare settings in the developing world where conventional laboratory infrastructure is unavailable.
Companies that use Diagnostics For All
Customer profileSegments1 record
Ideal customer profiles1 record
Diagnostics For All technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Diagnostics For All partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Diagnostics For All competitors and assessment
Company assessmentBroad incumbents
- QuidelOrtho: Large diagnostics company with rapid immunoassay and POC products used in clinical and global health settings. Comparable in product class (rapid diagnostics) but with a much broader and more commercial portfolio.
- HemoCue (Danaher): Danaher-owned POC diagnostics franchise focused on hemoglobin, glucose, and other blood-based rapid tests, with significant deployment in global health and emerging markets. Comparable POC diagnostic platform serving overlapping customer needs in resource-limited settings.
- Bio-Rad Laboratories: Large life science and clinical diagnostics manufacturer with significant global health and infectious disease diagnostic offerings. Overlaps with DFA in the broader diagnostics category, though Bio-Rad is substantially larger and more diversified.
- Chembio Diagnostics: Public POC diagnostics company with a portfolio of rapid tests for infectious disease, sexual health, and tropical diseases. Comparable in product category and end markets, though Chembio operates a broader commercial portfolio at greater scale.
- EKF Diagnostics: UK-listed POC diagnostics company with a broad portfolio of hemoglobin, glucose, and infectious disease rapid tests sold globally, including in developing-world healthcare channels. Overlapping POC category and customer base.
- Abbott Point of Care: A business unit of Abbott focused on POC diagnostics (e.g., i-STAT), serving hospitals and global health programs. A broad incumbent whose POC platform directly competes for the same institutional and global-health buyers DFA targets.
Direct peers
- Mologic: UK-based developer of lateral flow and rapid diagnostic tests focused on global health, agricultural, and at-home applications. Highly comparable to DFA in mission, technology class (rapid diagnostics), and target customer segments in the developing world.
- Atomo Diagnostics: Developer of integrated rapid diagnostic test platforms (e.g., HIV, malaria) designed for use in low-resource settings. Direct competitor in the low-cost POC diagnostics category serving global health markets.
- Diagnostics for the Real World: Cambridge-spinout (founded by Helen Lee) developing low-cost, rapid POC diagnostic tests for HIV and other infectious diseases in resource-limited settings. The most direct peer to Diagnostics For All given the shared mission of low-cost POC diagnostics for the developing world.
Emerging players
- Micronics (Sony): Originally a paper microfluidics-focused developer acquired by Sony, working on cartridge-based POC diagnostic devices. Direct technology-class peer to DFA in paper microfluidics, though now operating within a large parent and focused on commercialized cartridge products.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Diagnostics For All social profiles
Digital presenceDiagnostics For All financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diagnostics For All leadership team
Management profileNumber of profiles
Profiles2 records
Diagnostics For All funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diagnostics For All M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diagnostics For All
What does Diagnostics For All do?
Diagnostics For All develops and produces low-cost paper-based diagnostic tools using proprietary paper microfluidics technology. The devices are designed for point-of-care testing in resource-limited healthcare settings in the developing world, where conventional laboratory diagnostics are unavailable or unaffordable, enabling early disease detection and improved health outcomes in underserved populations.
Is Diagnostics For All a public or private company?
Diagnostics For All is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Diagnostics For All founded?
Diagnostics For All was founded in 2007. It employs 11 to 50 people.
Where is Diagnostics For All based?
Diagnostics For All is headquartered in Salem, United States, in the North America region.
Who are Diagnostics For All's main competitors?
Broad incumbents on record are QuidelOrtho, HemoCue (Danaher), Bio-Rad Laboratories, Chembio Diagnostics, EKF Diagnostics and Abbott Point of Care. Direct peers are Mologic, Atomo Diagnostics and Diagnostics for the Real World. Micronics (Sony) is listed as an emerging player.
Does Diagnostics For All have an API?
No public API is recorded for Diagnostics For All.
What industry is Diagnostics For All in?
Diagnostics For All's product category is Point-of-Care Diagnostics. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 339112 and its SIC code is 2835.